The director and chief research scientist at Tisch MS Research Center of New York talked about a phase 2 data study on stem cell treatment for multiple sclerosis that was presented at the 2023 AAN Annual Meeting. [WATCH TIME: 7 minutes]
Saud A. Sadiq, MD, FAAN
Advertisement
Director and chief research scientist at Tisch MS Research Center of New York.
Articles by Saud A. Sadiq, MD, FAAN
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
New Phase 3 Study to Evaluate Remibrutinib in Generalized Myasthenia Gravis Treatment
2
Early-Stage Study to Test CD19 CAR T-Cell Therapy YTB323 in Myasthenia Gravis
3
FDA Approves Doxecitine and Doxribtimine Combination Therapy as First Treatment for Thymidine Kinase 2 Deficiency
4
Jessica Neil, PA, on the Evolution of Patients With Headache
5
